Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
CYTOKINETICS INC (CYTK) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 144 Form 144 - Report of proposed sale of securities:
10/06/2023 8-K Other Events  Interactive Data
10/06/2023 144 Form 144 - Report of proposed sale of securities:
10/02/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Cytokinetics, Incorporated Executive Severance Plan and Summary Plan Description",
"Cytokinetics, Incorporated Executive Severance Plan and Summary Plan Description"
08/25/2023 144 Form 144 - Report of proposed sale of securities:
08/21/2023 144 Form 144 - Report of proposed sale of securities:
08/11/2023 144 Form 144 - Report of proposed sale of securities:
08/10/2023 144 Form 144 - Report of proposed sale of securities:
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "CYTOKINETICS REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS Completed Enrollment in SEQUOIA-HCM, Pivotal Phase 3 Trial of Aficamten in Obstructive HCM; On Track for Topline Results by the End of the Year Initiated Enrollment in MAPLE-HCM, a Phase 3 Clinical Trial Comparing Aficamten and Metoprolol in Obstructive HCM ACACIA-HCM, a Pivotal Phase 3 Clinical Trial of Aficamten in Non-Obstructive HCM, Expected to Start in September 2023 Company Reduces Projected Spending by Approximately 15% and Revises 2023 Financial Spending Guidance SOUTH SAN FRANCISCO, Calif., Aug. 3, 2023 -"
08/01/2023 144 Form 144 - Report of proposed sale of securities:
07/13/2023 144 Form 144 - Report of proposed sale of securities:
07/13/2023 144 Form 144 - Report of proposed sale of securities:
07/07/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/12/2023 144 Form 144 - Report of proposed sale of securities:
06/08/2023 144 Form 144 - Report of proposed sale of securities:
05/31/2023 144 Form 144 - Report of proposed sale of securities:
05/22/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "CYTOKINETICS PRESENTS NEW DATA IN PATIENTS WITH NON-OBSTRUCTIVE HCM FROM COHORT 4 OF REDWOOD-HCM IN LATE-BREAKING CLINICAL TRIAL SESSION AT THE EUROPEAN SOCIETY OF CARDIOLOGY HEART FAILURE 2023 CONGRESS Treatment of Aficamten was Well-Tolerated and Associated with Statistically Significant Improvements in KCCQ, Angina Frequency, NYHA Class, NTpro-BNP and High-Sensitivity Troponin I Phase 3 Clinical Trial in Non-Obstructive HCM To Begin in 2H 2023 SOUTH SAN FRANCISCO, Calif., May 20, 2023"
05/16/2023 144 Form 144 - Report of proposed sale of securities:
05/15/2023 144 Form 144 - Report of proposed sale of securities:
05/11/2023 144 Form 144 - Report of proposed sale of securities:
05/11/2023 8-K Other Events  Interactive Data
05/11/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/05/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
05/03/2023 144 Form 144 - Report of proposed sale of securities:
04/14/2023 144 Form 144 - Report of proposed sale of securities:
04/13/2023 144 Form 144 - Report of proposed sale of securities:
03/31/2023 8-K Quarterly results
03/27/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
03/06/2023 8-K Other Events  Interactive Data
03/01/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/01/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy